Bridging Supply Chain Gaps For mRNA Vaccines
mRNA vaccines need to be shipped and stored at extremely low temperatures, meaning mRNA clinical trial supply chains must be extra-robust to overcome logistics challenges.
Challenges in the mRNA vaccine supply chain
As mRNA vaccines take center stage, the challenges surrounding their formulation and stability have become apparent. One of the major challenges of mRNA vaccine technology is its dependency on cold chain shipping and storage. Vaccines need to be shipped and stored at very low temperatures. This requires freezers capable of handling temperatures of −80°C; not readily available at every clinical trial site. With vaccines subject to strict regulatory controls, the right cold chain shipping infrastructure must be in place if mRNA vaccines are to realize their full potential.
Logistics companies are playing an important role in building reliability in healthcare supply chains. This means end-to-end solutions for storage and transportation at specific temperatures, from the point of manufacture to the healthcare facilities where they will be used. As a trusted partner in clinical trial and healthcare logistics, FedEx is well-positioned to handle mRNA vaccine shipments around the world. Since 2020, we’ve supported shipments of COVID-19 vaccines to more than 60 countries and territories around the world.
Our cold chain storage facilities are temperature-controlled with a monitoring system to protect shipments before and after transit, including down to −80°C. During shipments, high-performance reusable thermal packaging supports the temperature requirements specified by the manufacturer. We provide 96 hours of temperature stability to keep contents healthy and viable in case of unexpected emergencies.
Pharmaceutical companies around the world are continuing to advance COVID-19 vaccines to respond to new strains of the virus. The lessons learned in COVID-19 vaccine design and production are also being reapplied to treat other viruses. Fortunately, logistics service providers like FedEx are transforming rapidly to keep pace with scientific breakthroughs. That way, we can ensure the safe delivery of promising new treatments that help save lives.
For more information on our cold chain and clinical trial logistics solutions, head to our Healthcare page now.
A version of this article first appeared in Biospectrum Asia On December 6, 2022.
PreviousAre Online Marketplaces The Future Of
Next3 Trends Retailers Can Capitalize On This Holiday Season
How To Tackle Healthcare Logistics Challenges In 2022
Building Reliability In Healthcare Supply Chains
The Impact Of Technology On The COVID Vaccine Supply Chain